Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP-Derived Exosomes for Erectile Dysfunction
NCT07124871Phase 2Recruiting
- Sponsor
- Institute for the Study of Urological Diseases
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in erectile dysfunction (ED), sponsored by Institute for the Study of Urological Diseases. Primary endpoint: Percentage of patients attaining Minimal Clinically Important Difference in IIEF-EF domain. Started Jun 2025; status: recruiting.
02
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07124871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124871.